Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003752694> ?p ?o ?g. }
- W2003752694 endingPage "561" @default.
- W2003752694 startingPage "557" @default.
- W2003752694 abstract "Rhabdomyosarcomas (RMS) represent the most common childhood soft-tissue sarcoma. Over the past few decades outcomes for low and intermediate risk RMS patients have slowly improved while patients with metastatic or relapsed RMS still face a grim prognosis. New chemotherapeutic agents or combinations of chemotherapies have largely failed to improve the outcome. Based on the identification of novel molecular targets, potential therapeutic approaches in RMS may offer a decreased reliance on conventional chemotherapy. Thus, identification of effective therapeutic agents that specifically target relevant pathways may be particularly beneficial for patients with metastatic and refractory RMS. The PI3K/AKT/mTOR pathway has been found to be a potentially attractive target in RMS therapy. In this study, we provide evidence that rapamycin (sirolimus) abrogates growth of RMS development in a RMS xenograft mouse model. As compared to a vehicle-treated control group, more than 95% inhibition in tumor growth was observed in mice receiving parenteral administration of rapamycin. The residual tumors in rapamycin-treated group showed significant reduction in the expression of biomarkers indicative of proliferation and tumor invasiveness. These tumors also showed enhanced apoptosis. Interestingly, the mechanism by which rapamycin diminished RMS tumor growth involved simultaneous inhibition of mTOR and hedgehog (Hh) pathways. Diminution in these pathways in this model of RMS also inhibited epithelial mesenchymal transition (EMT) which then dampened the invasiveness of these tumors. Our data provide bases for using rapamycin either alone or in combination with traditional chemotherapeutic drugs to block the pathogenesis of high risk RMS." @default.
- W2003752694 created "2016-06-24" @default.
- W2003752694 creator A5051957313 @default.
- W2003752694 creator A5063962585 @default.
- W2003752694 creator A5065887488 @default.
- W2003752694 creator A5071410072 @default.
- W2003752694 creator A5079917691 @default.
- W2003752694 creator A5091584403 @default.
- W2003752694 date "2013-06-01" @default.
- W2003752694 modified "2023-10-10" @default.
- W2003752694 title "Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model" @default.
- W2003752694 cites W1504229479 @default.
- W2003752694 cites W1926287352 @default.
- W2003752694 cites W1966802202 @default.
- W2003752694 cites W1967490691 @default.
- W2003752694 cites W1967511564 @default.
- W2003752694 cites W1976410067 @default.
- W2003752694 cites W1992981977 @default.
- W2003752694 cites W2003537331 @default.
- W2003752694 cites W2013453542 @default.
- W2003752694 cites W2025823278 @default.
- W2003752694 cites W2048851591 @default.
- W2003752694 cites W2054780042 @default.
- W2003752694 cites W2066439079 @default.
- W2003752694 cites W2067942082 @default.
- W2003752694 cites W2074708554 @default.
- W2003752694 cites W2088363975 @default.
- W2003752694 cites W2119501563 @default.
- W2003752694 cites W2123081410 @default.
- W2003752694 cites W2133022117 @default.
- W2003752694 cites W2137184839 @default.
- W2003752694 cites W2137480884 @default.
- W2003752694 cites W2143010317 @default.
- W2003752694 cites W2150189655 @default.
- W2003752694 doi "https://doi.org/10.1016/j.bbrc.2013.05.001" @default.
- W2003752694 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23665330" @default.
- W2003752694 hasPublicationYear "2013" @default.
- W2003752694 type Work @default.
- W2003752694 sameAs 2003752694 @default.
- W2003752694 citedByCount "25" @default.
- W2003752694 countsByYear W20037526942013 @default.
- W2003752694 countsByYear W20037526942014 @default.
- W2003752694 countsByYear W20037526942015 @default.
- W2003752694 countsByYear W20037526942016 @default.
- W2003752694 countsByYear W20037526942017 @default.
- W2003752694 countsByYear W20037526942018 @default.
- W2003752694 countsByYear W20037526942019 @default.
- W2003752694 countsByYear W20037526942020 @default.
- W2003752694 countsByYear W20037526942021 @default.
- W2003752694 countsByYear W20037526942022 @default.
- W2003752694 crossrefType "journal-article" @default.
- W2003752694 hasAuthorship W2003752694A5051957313 @default.
- W2003752694 hasAuthorship W2003752694A5063962585 @default.
- W2003752694 hasAuthorship W2003752694A5065887488 @default.
- W2003752694 hasAuthorship W2003752694A5071410072 @default.
- W2003752694 hasAuthorship W2003752694A5079917691 @default.
- W2003752694 hasAuthorship W2003752694A5091584403 @default.
- W2003752694 hasConcept C126322002 @default.
- W2003752694 hasConcept C142724271 @default.
- W2003752694 hasConcept C190283241 @default.
- W2003752694 hasConcept C2776694085 @default.
- W2003752694 hasConcept C2777921159 @default.
- W2003752694 hasConcept C2778256501 @default.
- W2003752694 hasConcept C2780844630 @default.
- W2003752694 hasConcept C502942594 @default.
- W2003752694 hasConcept C55493867 @default.
- W2003752694 hasConcept C71924100 @default.
- W2003752694 hasConcept C75217442 @default.
- W2003752694 hasConcept C86554907 @default.
- W2003752694 hasConcept C86803240 @default.
- W2003752694 hasConcept C98274493 @default.
- W2003752694 hasConceptScore W2003752694C126322002 @default.
- W2003752694 hasConceptScore W2003752694C142724271 @default.
- W2003752694 hasConceptScore W2003752694C190283241 @default.
- W2003752694 hasConceptScore W2003752694C2776694085 @default.
- W2003752694 hasConceptScore W2003752694C2777921159 @default.
- W2003752694 hasConceptScore W2003752694C2778256501 @default.
- W2003752694 hasConceptScore W2003752694C2780844630 @default.
- W2003752694 hasConceptScore W2003752694C502942594 @default.
- W2003752694 hasConceptScore W2003752694C55493867 @default.
- W2003752694 hasConceptScore W2003752694C71924100 @default.
- W2003752694 hasConceptScore W2003752694C75217442 @default.
- W2003752694 hasConceptScore W2003752694C86554907 @default.
- W2003752694 hasConceptScore W2003752694C86803240 @default.
- W2003752694 hasConceptScore W2003752694C98274493 @default.
- W2003752694 hasIssue "4" @default.
- W2003752694 hasLocation W20037526941 @default.
- W2003752694 hasLocation W20037526942 @default.
- W2003752694 hasOpenAccess W2003752694 @default.
- W2003752694 hasPrimaryLocation W20037526941 @default.
- W2003752694 hasRelatedWork W1988747615 @default.
- W2003752694 hasRelatedWork W2145454786 @default.
- W2003752694 hasRelatedWork W2278983970 @default.
- W2003752694 hasRelatedWork W2362061149 @default.
- W2003752694 hasRelatedWork W2603762427 @default.
- W2003752694 hasRelatedWork W2912656088 @default.
- W2003752694 hasRelatedWork W2974310060 @default.
- W2003752694 hasRelatedWork W3006030203 @default.